Exp Mol Med.
2001 Sep;33(3):145-149.
Development of a packaging cell line for propagation of replication-deficient adenovirus vector
- Affiliations
-
- 1Clinical Research Center, Samsung Biomedical Research Institute, Seoul, Korea.
Abstract
- A human embryonic kidney cell line 293 is widely used for adenovirus production and propagation. With this cell line, however, replication-competent virus (RCV) is frequently generated, especially during large-scale production and successive propagation because 293 cells contain not only E1 gene but also non-E1 adenovirus gene. Homologous recombination between non-E1 region of 293 genomic DNA and its homologous region in the recombinant adenoviral vector generate RCV. To overcome this problem, we developed a new packaging cell line, Hela-E1, which contains minimum E1 region and from which non-E1 adenoviral region that is homologous with recombinant adenovirus vector was excluded. No RCV was detected during adenovirus propagation in Hela-E1 compared to in 293. In addition, adenovirus-p53 produced in HeLa-E1 was able to overexpress p53 protein when introduced into an ovarian cancer cell line, SKOV3. These results may have a significant impact on the development of packaging cell lines for replication-deficient adenovirus production.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Adenovirus Vector-mediated Gene Transfer into Human Trabecular Cell
- Adenovirus Vectors: Excellent Tools for Vaccine Development
- Construction of Recombinant Adeno-Associated Virus Vector (AAVCMVp53) for Human Cervical Cancer Gene Therapy
- Stromelysin Gene Expression in Rat Eye Mediated by the Adenovirus Vector
- Identification of Retroviral Vectors Producing High Viral Titer
